Leonard Green & Partners Leads Recapitalization of WCG with Arsenal and Novo Holdings

November 14, 2019

An investor group led by Leonard Green & Partners, in partnership with Arsenal Capital Partners and Novo Holdings A/S, has agreed to recapitalize WCG to provide resources to accelerate growth and expand capabilities in clinical trial optimization. Financial terms were not disclosed; the transaction was announced in November 2019 and expected to close in the first quarter of 2020.

Buyers
Leonard Green & Partners, Arsenal Capital Partners, Novo Holdings A/S
Targets
WCG
Location
North Carolina, United States
Transaction Type
Recapitalization

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.